PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22678099-8	2012	Sazetidine-A effects were mediated by beta2* nAChR subtypes, whereas varenicline actions were attributed to alpha3beta4 nAChRs.	sazetidine-A	0-12	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	45-50	
29355641-11	2018	Collectively, these data suggest a novel role for the nAChR targets of sazetidine-A in specifically mediating alcohol consumption, separate from the involvement of nAChRs in mediating nicotine consumption.	sazetidine-A	71-83	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	54-59	
29587798-9	2018	administration of TC-2559 and sazetidine A, a partial agonist for alpha4beta2 nAChR, during either the early or middle phase of PSL improved mechanical allodynia.	sazetidine-A	30-42	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	78-83	
22678099-11	2012	In contrast, both actions of sazetidine-A are mediated by beta2*-nAChR subtypes.	sazetidine-A	29-41	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	65-70	
32329567-3	2021	We previously reported that the preclinical drug sazetidine-A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice.	sazetidine-A	49-61	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	65-70	
21487659-2	2011	OBJECTIVES: The study determined whether the antidepressant-like effect of the nAChR beta2* partial agonist sazetidine-A (sazetidine) in the forced swim test was due to activation or desensitization of beta2* nAChRs.	sazetidine-A	108-120	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	79-84